NCT02030860 2025-07-25
A Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
Clinical Trials
4 trialsNCT03490760 2023-10-12
Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the Pancreas
Baptist Health South Florida
Phase 2 Terminated
NCT01357525 2021-11-24
SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma
University of Pittsburgh
Phase NA Completed
NCT01401387 2013-02-22
EPC
Foundation for Liver Research
Phase 4 Withdrawn